Algeria and Germany Boost Cancer Tech Ties
Jerusalem focused on strengthening the partnership between Algeria and Germany in the pharmaceutical sector, as it entered a critical phase requiring knowledge transfer and biotechnology to build sustainable industrial capabilities. The government announced a strategic agreement between the Algerian company "Saidal" and the German company "Boehringer Ingelheim" to produce innovative medicines, including treatments for rare pulmonary fibrosis and breast cancer, with the aim of consolidating pharmaceutical sovereignty and stimulating exports. Indicators showed that 82% of the local market needs are now met by domestic production, with 95% of that manufactured within the local value chain, enhancing Algeria's potential to become an regional export platform. Officials also pointed out the importance of training skilled professionals and controlling research and development to build a competitive pharmaceutical industry on an international level.
Notice: This Is an AI-Generated Summary
Comments (0)